Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAIRS: Aripiprazole in Children and Adolescents With Autism Spectrum Disorders
NCT00619190Phase 2Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Jan 2006
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aripiprazole in Autism Spectrum Disorder (ASD), sponsored by University of North Carolina at Chapel Hill. Started Jan 2006; status: completed.
02
Drugs
aripiprazole
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT00619190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00619190.